First Potomac Realty Trust (NYSE:FPO) shares fell -1.87% in last trading session and ended the day at $10.52. FPO Gross Margin is 62.80% and its has a return on assets of -0.50%. First Potomac Realty Trust (NYSE:FPO) quarterly performance is -7.73%.
First Potomac Realty Trust (NYSE:FPO), a leading owner and operator of office and business park properties in the greater Washington D.C. region, announced two lease transactions totaling 5,661 square feet at 840 First Street, NE in Washington, D.C., bringing the property to 100% leased.
American Tower Corporation (NYSE:AMT) ended the last trading day at $94.48. Company weekly volatility is calculated as 1.74% and price to cash ratio as 132.56. American Tower Corporation (NYSE:AMT) showed a weekly performance of -4.19%.
On 8 January, American Tower Corporation (NYSE:AMT) announced the pricing of its registered public offering of senior unsecured notes due 2021 and 2026, in aggregate principal amounts of $750.0 million and $500.0 million, respectively. The 2021 notes will have an interest rate of 3.300% per annum and are being issued at a price equal to 99.853% of their face value. The 2026 notes will have an interest rate of 4.400% per annum and are being issued at a price equal to 99.713% of their face value. The net proceeds of the offering are expected to be approximately $1,237.2 million, after deducting underwriting discounts and estimated offering expenses.
On 12 January, Samson Oil & Gas Limited (NYSEMKT:SSN) shares fell -18.35% and was closed at $0.49. SSN EPS growth in last 5 year was -18.20%. Samson Oil & Gas Limited (NYSEMKT:SSN) year to date (YTD) performance is 23.99%.
Samson Oil and Gas USA Inc (NYSE MKT: SSN)) has entered into a contract to acquire a parcel of oil and gas leases, producing oil and gas wells, currently shut-in wells and associated facilities in North Dakota and Montana for a cash price of $16.5 million.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares moved up 3.72% in last trading session and ended the day at $8.08. BCRX Gross Margin is 97.10% and its has a return on assets of -25.80%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) quarterly performance is -11.31%.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced that executives from BioCryst presented and provide a corporate summary and update regarding the Company’s development programs at the 34th annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 13, 2016 at 9:00 a.m. Pacific Time.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) caters to the Healthcare space. Its weekly performance is -22.88%. On the last day of trading company shares ended up at $5.90. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) distance from 50-day simple moving average (SMA50) is -1.11%.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced that Josh Blacher, Chief Financial Officer, presented a company overview at the Eighth Annual Biotech Showcase™ conference in San Francisco, California, on Tuesday, January 12, 2016 at 10:30 AM Pacific Standard Time.
Leave a Reply